Table 1.
Patient clinical characteristics and detection level of F. nucleatum
| Clinical Characteristic |
Total Number of Patients | Total Detect Number |
Samples for detect F. nucleatum (N = 98) |
||
|---|---|---|---|---|---|
| Positive | Negative | P-value | |||
| 111 | 98 | 68(69.4%) | 30(29.6%) | ||
| Age (mean, range) | |||||
| 62.9 ± 7.1 | |||||
| < 60 | 31(27.9%) | 29 | 22(75.9%) | 7(24.1%) | 0.1412 |
| > 60 | 80(72.7%) | 69 | 46(66.7%) | 23(33.3%) | |
| Gender | |||||
| Male | 64(57.7%) | 56 | 39(69.6%) | 17(30.4%) | 0.9989 |
| Female | 47(42.3%) | 42 | 29(69%) | 13(31%) | |
| Smoking | |||||
| Yes | 44(39.6%) | 39 | 26(66.7%) | 13(33.3%) | 0.9428 |
| No | 67(60.4%) | 59 | 42(71.2%) | 17(28.8%) | |
| Drinking | |||||
| Yes | 46(41.4%) | 39 | 25(64.1%) | 14(35.9%) | 0.5561 |
| No | 65(58.6%) | 59 | 43(72.9%) | 16(28.8%) | |
| Histopathological grading | |||||
| G1–2 | 79(71.2%) | 72 | 50(69.4%) | 22(30.6%) | 0.5305 |
| G3 | 32(28.8%) | 26 | 18(69.2%) | 8(30.8%) | |
| clinical T stage (pT) | |||||
| pT1–2 | 44(39.6%) | 35 | 24(68.6%) | 11(31.4%) | 0.039 |
| pT3–4 | 67(60.4%) | 63 | 44(69.8%) | 19(30.2%) | |
| lymph node | |||||
| pN0–1 | 97(87.4%) | 89 | 61(68.5%) | 28(31.5%) | 0.1343 |
| pN2–3 | 14(12.6%) | 9 | 7(77.8%) | 2(22.2%) | |
| Clinical tumor stage | |||||
| I | 8(7.2%) | 4 | 3(75%) | 1(25%) | 0.0033 |
| II | 71(64%) | 68 | 44(64.7%) | 24(35.3%) | |
| III | 32(28.8%) | 26 | 21(84%) | 5(15.4%) | |